Ioana
Ioana Bacivarov, Galway IE
Patent application number | Description | Published |
---|---|---|
20080205712 | Separating Directional Lighting Variability in Statistical Face Modelling Based on Texture Space Decomposition - A technique for determining a characteristic of a face or certain other object within a scene captured in a digital image including acquiring an image and applying a linear texture model that is constructed based on a training data set and that includes a class of objects including a first subset of model components that exhibit a dependency on directional lighting variations and a second subset of model components which are independent of directional lighting variations. A fit of the model to the face or certain other object is obtained including adjusting one or more individual values of one or more of the model components of the linear texture model. Based on the obtained fit of the model to the face or certain other object in the scene, a characteristic of the face or certain other object is determined. | 08-28-2008 |
20090003661 | Separating a Directional Lighting Variability In Statistical Face Modelling Based On Texture Space Decomposition - A technique for determining a characteristic of a face or certain other object within a scene captured in a digital image including acquiring an image and applying a linear texture model that is constructed based on a training data set and that includes a class of objects including a first subset of model components that exhibit a dependency on directional lighting variations and a second subset of model components which are independent of directional lighting variations. A fit of the model to the face or certain other object is obtained including adjusting one or more individual values of one or more of the model components of the linear texture model. Based on the obtained fit of the model to the face or certain other object in the scene, a characteristic of the face or certain other object is determined. | 01-01-2009 |
20110007174 | Identifying Facial Expressions in Acquired Digital Images - A face is detected and identified within an acquired digital image. One or more features of the face is/are extracted from the digital image, including two independent eyes or subsets of features of each of the two eyes, or lips or partial lips or one or more other mouth features and one or both eyes, or both. A model including multiple shape parameters is applied to the two independent eyes or subsets of features of each of the two eyes, and/or to the lips or partial lips or one or more other mouth features and one or both eyes. One or more similarities between the one or more features of the face and a library of reference feature sets is/are determined. A probable facial expression is identified based on the determining of the one or more similarities. | 01-13-2011 |
20130300891 | Identifying Facial Expressions in Acquired Digital Images - A face is detected and identified within an acquired digital image. One or more features of the face is/are extracted from the digital image, including two independent eyes or subsets of features of each of the two eyes, or lips or partial lips or one or more other mouth features and one or both eyes, or both. A model including multiple shape parameters is applied to the two independent eyes or subsets of features of each of the two eyes, and/or to the lips or partial lips or one or more other mouth features and one or both eyes. One or more similarities between the one or more features of the face and a library of reference feature sets is/are determined. A probable facial expression is identified based on the determining of the one or more similarities. | 11-14-2013 |
20150269424 | IDENTIFYING FACIAL EXPRESSIONS IN ACQUIRED DIGITAL IMAGES - A face is detected and identified within an acquired digital image. One or more features of the face is/are extracted from the digital image, including two independent eyes or subsets of features of each of the two eyes, or lips or partial lips or one or more other mouth features and one or both eyes, or both. A model including multiple shape parameters is applied to the two independent eyes or subsets of features of each of the two eyes, and/or to the lips or partial lips or one or more other mouth features and one or both eyes. One or more similarities between the one or more features of the face and a library of reference feature sets is/are determined. A probable facial expression is identified based on the determining of the one or more similarities. | 09-24-2015 |
Ioana Combaluzier, Urdorf CH
Patent application number | Description | Published |
---|---|---|
20150210759 | HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF - Provided are novel human islet amyloid polypeptide, also known as amylin and IAPP and proIAPP respectively, specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for IAPP and/or proIAPP are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for IAPP and/or proIAPP targeted immunotherapy and diagnostics, respectively. | 07-30-2015 |
Ioana Craiciu, Calgary CA
Patent application number | Description | Published |
---|---|---|
20150284591 | COATING FOR ROOFTOPS AND METHOD OF MANUFACTURE FOR SAME - The disclosure is directed at a coating for rooftops or rooftop structures which is in a reflective state at a first temperature and in a non-reflective state at a second temperature. During colder months, the coating is in the non-reflective state while at warmer temperatures, the coating is in a reflective state. | 10-08-2015 |
Ioana Drutu, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20100311720 | Spiroindoline Modulators of Muscarinic Receptors - The present invention relates to spiroindoline modulators of muscarinic receptors. The present invention also provides compositions comprising such spiroindoline modulators, and methods therewith for treating muscarinic receptor mediated diseases. | 12-09-2010 |
Ioana Drutu, Watertown, MA US
Patent application number | Description | Published |
---|---|---|
20120283243 | Spiroindoline Modulators of Muscarinic Receptors - The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. | 11-08-2012 |
20130281476 | Modulators of Muscarinic Receptors - The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases. | 10-24-2013 |
Ioana Firastrau, Jud. Brasov RO
Patent application number | Description | Published |
---|---|---|
20100039181 | SPIN-TRANSFER TORQUE OSCILLATOR - The invention relates to a method of operating a spin-transfer torque structure to generate voltage oscillations, said structure comprising a first layer of magnetic material having a fixed magnetization vector, a spacer of non magnetic material and a second layer of magnetic material having a free magnetization vector. The method includes the application of a current (j | 02-18-2010 |
Ioana Genata, Colomiers FR
Patent application number | Description | Published |
---|---|---|
20130274991 | Method, devices and program for computer-aided analysis of the failure tolerance of an aircraft system, using critical event charts - Aided analysis of the failure tolerance of an aircraft system, comprising a plurality of subsystems at least one of which comprises a monitoring unit and notification of a detected event, using critical event charts. After selecting at least one receivable notification message represented by a node of the critical event chart, elements of the minimal diagnostic set capable of resulting in the generation of the at least one selected notification message are identified, the identified elements forming part of the failure tolerance report. | 10-17-2013 |
Ioana Kloos, Rueil Maimaison FR
Patent application number | Description | Published |
---|---|---|
20130064880 | ADMINISTRATION REGIME FOR N-HYDROXY-4-BENZAMIDE - N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}-benzamide of formula (I): | 03-14-2013 |
Ioana Kloos, Rueil Malmaison FR
Patent application number | Description | Published |
---|---|---|
20140341989 | FORMULATIONS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND USES THEREOF - Dosing regimens, methods of treatment, controlled release formulations, and combination therapies that include bendamustine, or a pharmaceutically acceptable salt thereof and an HDAC inhibitor, or a pharmaceutically acceptable salt thereof, are described. | 11-20-2014 |
20150024040 | ADMINISTRATION REGIME FOR N-HYDROXY-4-BENZAMIDE - N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}-benzamide of formula (I): | 01-22-2015 |
20150038513 | ASSOCIATION BETWEEN N-HYDROXY-4-BENZAMIDE AND FOLFOX - Association between N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2-yl-carbonylamino]ethoxy}benzamide of formula (I): | 02-05-2015 |
Ioana Lupascu, Waltham, MA US
Patent application number | Description | Published |
---|---|---|
20140154703 | CIRCULATING TUMOR CELL CAPTURE ON A MICROFLUIDIC CHIP INCORPORATING BOTH AFFINITY AND SIZE - The invention encompasses methods and devices for diagnosing, theranosing, or prognosing a condition in a patient by enriching a sample in rare cells or other particles. The devices can be a microfluidic device comprising an array of obstacles and one or more binding moieties. The devices and methods can allow for enrichment of cells based on size and affinity, recovery of cells or other particles in locations on the microfluidic device, release of cells or other particles from the microfluidic device, flow of sample through the microfluidic device, and retention of rare cells or other particles from a sample obtained from a patient having a condition. | 06-05-2014 |